AHL Partners’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-33,876
Closed -$507K – 1410
2017
Q3
$507K Sell
33,876
-14,279
-30% -$224K 0.01% 1043
2017
Q2
$893K Sell
48,155
-4,097
-8% -$71.2K 0.02% 809
2017
Q1
$882K Buy
+52,252
New +$1.04M 0.02% 811
2016
Q4
– Sell
-19,072
Closed -$348K – 1240
2016
Q3
$348K Buy
19,072
+10,806
+131% +$244K 0.01% 946
2016
Q2
$239K Buy
+8,266
New +$230K 0.01% 750

Other funds holding ARA

AHL Partners's ARA Position: Q4 2017 in Review

AHL Partners sold out of American Renal Associates Holdings, Inc (ARA) in Q4 2017, closing a stake of 33,876 shares — an estimated $507K sold.

AHL Partners first reported a position in ARA in Q2 2016 and held it in 5 quarters. The position peaked at $893K in Q2 2017. 80 funds tracked by Wall St. Rank hold ARA as of Q4 2017.

  • AHL Partners reported no remaining American Renal Associates Holdings, Inc position as of Q4 2017 after selling out during the quarter.
  • AHL Partners sold 33,876 American Renal Associates Holdings, Inc shares in Q4 2017, an estimated $507K.
  • AHL Partners first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 5 quarters.
  • AHL Partners's American Renal Associates Holdings, Inc position peaked at $893K in Q2 2017.
  • 80 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.